Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1984-09-24
1986-01-07
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 10, 514 11, 514 8, 2601125R, 424118, A61K 3700, A61K 3500, C07C10352
Patent
active
045634424
ABSTRACT:
New glycopeptide antibiotics of the formula: ##STR1## wherein W is the remaining portion of a glycopeptide antibiotic selected from actaplanin factors B.sub.1, B.sub.2, B.sub.3, C.sub.1, C.sub.2, C.sub.3, D.sub.1, D.sub.2, E.sub.1, G, K, L, M, N, O and actaplanin .psi.aglycone, and salts thereof, particularly the pharmaceutically acceptable salts, are useful new antibiotics are active against gram-positive bacteria and increase feed-efficiency utilization and enhance milk production in ruminants.
REFERENCES:
patent: 3928571 (1975-12-01), Raun
patent: 3952095 (1976-04-01), Hamill et al.
patent: 4064233 (1977-12-01), Hamill et al.
patent: 4115552 (1978-09-01), Hamill et al.
patent: 4322343 (1982-03-01), Debono
patent: 4322406 (1982-03-01), Debono et al.
patent: 4461723 (1984-07-01), Hershberger et al.
M. Debono, "Structure and Activity of New Glycopeptide Antibiotics," oral presentation at 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Las Vegas, Nevada, 1983, notes for relevant part of talk.
Anderson Marie T.
Boeck LaVerne D.
Clem Gladys M.
Michel Karl H.
Eli Lilly and Company
Harrison Nancy J.
Phillips Delbert R.
Whale Arthur R.
LandOfFree
Glycopeptide bioconversion products does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycopeptide bioconversion products, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycopeptide bioconversion products will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-111789